Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which account for more than 25% of the company’s total revenues. Pfizer’s key ...

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Doses of the COVID-19 vaccine purchased through the federally funded Vaccines for Children program only started arriving this ...

Jeffrey Friedman, whose 1994 discovery of the hormone leptin changed how obesity is understood and treated, was awarded by ...

Key Points Sold entire holding of 109,630 shares; estimated trade value of approximately $2.66 million based on the quarterly average price Stake was previously 1.2% of fund AUM as of the prior ...

QSM Asset Management added 276,899 shares of Pfizer for an estimated $6.8 million in the third quarter. After the transaction ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

Shares in Pfizer fell on Monday after rival drugmaker Moderna said its experimental vaccine against COVID-19 was 94.5% effective and that it can be stored at normal fridge temperatures.